Antiapoptotic and protective effects of roscovitine on ischemia–reperfusion injury of the rat liver

  1. Serdar Topaloglu1,
  2. Osman Abbasoglu1,
  3. Ayse Ayhan2,
  4. Cenk Sokmensuer2,
  5. Kamer Kılınc3

Article first published online: 30 JUL 2003

DOI: 10.1034/j.1600-0676.2003.00842.x

Issue

Liver International

Liver International

Volume 23, Issue 4, pages 300–307, August 2003

Additional Information

How to Cite

Topaloglu, S., Abbasoglu, O., Ayhan, A., Sokmensuer, C. and Kılınc, K. (2003), Antiapoptotic and protective effects of roscovitine on ischemia–reperfusion injury of the rat liver. Liver International, 23: 300–307. doi: 10.1034/j.1600-0676.2003.00842.x

Author Information

  1. 1

    Department of Surgery, Hacettepe University School of Medicine, Ankara, Turkey

  2. 2

    Department of Pathology, Hacettepe University School of Medicine, Ankara, Turkey

  3. 3

    Department of Biochemistry, Hacettepe University School of Medicine, Ankara, Turkey

*Osman Abbasoglu, GAMA Sitesi Cayeli sok. No. 1, 06530 Cayyolu, Ankara, Turkey. Tel: +90 312 305 1676. Fax: +90 312 417 1783. e-mail: osmanabbasoglu@yahoo.com

Publication History

  1. Issue published online: 30 JUL 2003
  2. Article first published online: 30 JUL 2003
  3. Received 23 December 2002, accepted 16 April 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (875K)

Keywords:

  • ischemia;
  • reperfusion injury;
  • apoptosis;
  • roscovitine;
  • liver

Abstract

Objective: This study was designed to investigate the role of apoptosis on liver IR injury and to determine the effects of roscovitine on this process.

Materials and methods: Rat livers pretreated with roscovitine received 60 min right lobe ischemia followed by 4 h (n=8) and 24 h (n=8) reperfusion. Tissue injury was evaluated by serum alanine aminotransferase, aspartate aminotransferase, tissue malondialdehyde, myeloperoxidase measurements and histological examination. Dead (apoptotic and necrotic) hepatocytes were determined by trypan blue dye and apoptosis was evaluated with M30 monoclonal antibody.

Results: Administration of roscovitine significantly decreased both apoptotic and dead hepatocyte counts compared to controls (P<0.01). Liver transaminase levels were decreased significantly in the roscovitine-pretreated groups (P<0.05). In the groups evaluated 24 h after reperfusion, MPO levels (P<0.02) and leukocyte infiltration on histologic sections were decreased significantly in the roscovitine-administered group compared to its control.

Conclusions: This study indicates that hepatocyte apoptosis may play a role in the development of IR injury of the liver. Administration of roscovitine may be beneficial in preventing this injury.

View Full Article (HTML) Get PDF (875K)